Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cubilin pseudogene 1 (CUBNP1) is a genomic sequence similar in sequence to the cubilin (intrinsic factor-cobalamin receptor) gene but does not encode a functional protein product. As a pseudogene, it does not participate in any known biological process, disease mechanism, or therapeutic interaction. The biological and pharmacological information applies to the functional cubilin gene (CUBN), not this pseudogene. CUBNP1 is a pseudogene and not a protein-coding gene. Pseudogenes are genomic DNA sequences similar to normal genes but generally nonfunctional; they are not transcribed into functional proteins. In contrast, the canonical CUBN (cubilin) gene encodes a functional receptor involved in vitamin B12 absorption and protein reabsorption in the kidney, and information about disease, drugs, or biological activity refers to the functional gene/protein, not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cubilin pseudogene 1 (CUBNP1).